This is a non-core endpoint: only basic statistics are computed.
Melanocytic naevi, other sites/unspecified
CD2_BENIGN_MELANOCYTIC_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus non specificatus
Similar endpoints
↥List of similar endpoints to
Melanocytic naevi, other sites/unspecified
based on the number of shared cases.
Similar with more cases:
- Melanocytic naevi, other sites/unspecified
- Melanocytic naevi
- Melanocytic naevi
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3117 | 1925 | 1192 |
| Unadjusted period prevalence (%) | 0.61 | 0.66 | 0.53 |
| Median age at first event (years) | 53.48 | 48.97 | 60.76 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2774
- Matched controls
- 27739
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
18.5
323.0
759
552
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
17.7
323.0
613
436
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
6202.2
323.0
2739
388
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
14.4
323.0
864
842
PJA12
NOMESCO Finland
Sentinel node biopsy
831.7
308.4
298
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
11.9
300.7
591
618
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
182.9
256.0
265
16
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
228.3
216
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
28.6
222.3
307
120
L57.0
ICD-10 Finland
Actinic keratosis
8.2
189.9
455
644
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
10.1
189.2
399
454
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
18.0
185.4
297
183
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
247.5
181.8
185
8
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
169.5
161
*
XQ845
NOMESCO Finland
Dermatoscopy
39.3
163.2
208
57
115
Kela drug reimbursment
Breast cancer
+∞
155.7
148
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
1529.2
148.2
143
*
130
Kela drug reimbursment
Malignant tumour
+∞
136.6
130
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
15.1
135.4
232
167
XQ848
NOMESCO Finland
Dermatological photography
13.1
134.3
245
204
C61
ICD-10 Finland
Malignant neoplasm of prostate
455.3
132.2
131
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.9
130.0
632
1972
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
127.0
121
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
124.9
119
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
3.8
123.5
606
1897
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
122.8
117
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
1100.0
109.2
106
*
SPAT1153
SPAT
Removal of sutures
2.7
108.9
1038
5091
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
105.9
101
*
H02AB02
ATC
dexamethasone; systemic
18.3
105.1
166
96
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
12.8
103.3
189
157
127
Kela drug reimbursment
Transplant complication
18.1
100.2
159
93
ZXC50
NOMESCO Finland
Cryotherapy
14.3
99.9
174
129
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
992.3
98.7
96
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
98.5
94
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
94.3
90
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
19.7
90.5
139
74
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
13.1
87.0
157
126
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
85.9
82
*
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
60.3
84.4
99
17
Z94.0
ICD-10 Finland
Kidney transplant status
19.0
78.6
122
67
A04AA02
ATC
granisetron; systemic, transdermal
109.5
78.3
85
8
L04AA06
ATC
mycophenolic acid; systemic
11.1
77.3
151
143
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
76.4
73
*
S18
ICPC
Laceration/cut
2.2
74.8
1174
7039
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
737.0
73.5
72
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
72.2
69
*
ZZR00
NOMESCO Finland
Flap of skin
24.6
71.5
102
43
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
69.0
66
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
70.8
66.5
76
11
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
65.9
63
*
TQW99
NOMESCO Finland
Other minor procedure on skin
6.0
65.8
192
342
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
24.4
63.1
90
38
116
Kela drug reimbursment
Prostate cancer
+∞
62.7
60
*
HAC20
NOMESCO Finland
Total mastectomy
166.2
62.2
65
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
19.0
60.8
94
51
HAB40
NOMESCO Finland
Wedge excision of mammary gland
26.9
58.4
81
31
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.1
58.2
166
287
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
57.5
55
*
L02BA01
ATC
tamoxifen; oral
41.0
57.5
72
18
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
57.2
848
4821
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
124.6
57.0
61
5
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
56.4
54
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
56.4
54
*
L03AA13
ATC
pegfilgrastim; parenteral
548.3
54.7
54
*
A04AA55
ATC
palonosetron, combinations; systemic
548.3
54.7
54
*
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
10.3
54.5
110
111
WF002
NOMESCO Finland
Radical radiotherapy
64.4
54.5
63
10
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
53.3
51
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
16.4
52.8
86
54
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
15.7
52.6
87
57
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
270.7
52.3
53
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
84.6
52.1
58
7
JN4BD
NOMESCO Finland
Extensive body CT
4.5
52.0
196
463
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
8.6
52.0
116
140
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.8
51.8
123
164
137
Kela drug reimbursment
Uraemia requiring dialysis
17.0
50.5
81
49
HA1AA
NOMESCO Finland
X-ray mammography
5.7
50.4
150
273
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
50.1
48
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
49.1
47
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
249.2
48.2
49
*
L01BC06
ATC
capecitabine; oral
+∞
48.0
46
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
8.7
48.0
106
126
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.1
47.7
121
178
L04AD01
ATC
ciclosporin; systemic
6.8
47.5
124
190
C50.99
ICD-10 Finland
Breast, unspecified
+∞
47.0
45
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
238.8
46.1
47
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
86.6
46.0
51
6
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
45.3
410
1823
S82
ICPC
Naevus/mole
2.5
45.1
406
1800
ZXC15
NOMESCO Finland
Use of photodynamic technique
21.8
44.9
66
31
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
44.9
43
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.0
44.9
188
491
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
444.4
44.3
44
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
83.2
44.0
49
6
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
43.9
42
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
15.4
43.3
72
48
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
42.8
41
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
41.8
714
4192
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
41.8
40
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
41.8
40
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
41.7
1032
6893
JN4AD
NOMESCO Finland
Body CT examination
5.0
41.7
139
289
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.5
41.3
204
612
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
40.7
39
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
40.7
39
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
40.7
39
*
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
+∞
40.7
39
*
TK800
NOMESCO Finland
Hemodialysis
7.0
40.1
102
151
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
53.0
39.6
47
9
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
5.9
39.4
114
201
TQW80
NOMESCO Finland
Local dermatologic skincare
5.2
39.1
125
248
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
5.9
38.6
111
194
WF049
NOMESCO Finland
Radiotherapy of metastasis
382.4
38.1
38
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
18.2
38.0
59
33
E0000UV
ATC
NA
1.7
37.5
1069
7393
S77
ICPC
Malignant neoplasm of skin
70.9
37.0
42
6
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
36.5
35
*
B05DA
ATC
Isotonic solutions
14.8
36.3
61
42
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
81.2
35.9
40
5
A12AA04
ATC
calcium carbonate; oral
7.5
35.2
85
117
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
34.3
345
1604
NK6AN
NOMESCO Finland
Total body bone isotope imaging
65.8
34.0
39
6
B03XA02
ATC
darbepoetin alfa; parenteral
8.0
33.9
78
100
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
121.5
33.7
36
*
D22
ICD-10 Finland
Melanocytic naevi
3.4
33.5
170
520
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
33.4
32
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
33.4
32
*
ZX080
NOMESCO Finland
Image guided radiotherapy
330.8
32.9
33
*
L04AA01
ATC
[U] ciclosporin; systemic
7.1
32.5
81
117
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
32.3
31
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
32.3
31
*
L02BG04
ATC
letrozole; oral
5.3
32.3
102
200
L03AA02
ATC
filgrastim; parenteral
62.4
32.1
37
6
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
29.1
32.0
43
15
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
43.9
31.8
39
9
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
31.3
30
*
A11CC03
ATC
alfacalcidol; systemic
5.3
31.1
97
188
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
316.2
30.9
31
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
30.3
29
*
180
Kela drug reimbursment
Interferon alfa
+∞
30.3
29
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.0
30.1
69
88
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.4
30.0
154
476
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
9.4
29.9
62
67
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.8
29.8
200
742
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
107.8
29.7
32
*
Z49.2
ICD-10 Finland
Other dialysis
13.2
29.6
52
40
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
50.6
29.4
35
7
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
11.7
29.1
54
47
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
9.8
28.6
58
60
B05DB
ATC
Hypertonic solutions
13.8
28.5
49
36
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
5.1
28.4
92
186
UJF32
NOMESCO Finland
Coloscopy
1.8
28.4
593
3663
B07.9
ICD-10 Finland
Verruca simplex
3.7
28.3
127
352
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
28.2
27
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
28.2
27
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
28.2
27
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
64.6
27.9
32
5
C43
ICD-10 Finland
Malignant melanoma of skin
284.2
27.8
28
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
101.0
27.7
30
*
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.8
27.2
93
200
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
27.1
26
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
27.1
26
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
27.1
26
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
27.1
26
*
A04AD12
ATC
aprepitant; systemic
273.5
26.8
27
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
273.5
26.8
27
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
26.5
142
453
ZX120
NOMESCO Finland
Intravenous
2.6
26.5
203
816
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
26.1
25
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
26.1
25
*
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
+∞
26.1
25
*
SPAT1312
SPAT
General health counselling
1.6
26.0
879
6210
D06BB10
ATC
imiquimod; topical
3.2
25.4
139
451
QAE00
NOMESCO Finland
Excision of loose skin or fold of skin from head and neck
28.6
25.4
34
12
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
7.9
25.2
58
75
Z31.5
ICD-10 Finland
Genetic counselling
3.2
25.1
138
449
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
25.0
24
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
25.0
24
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
25.0
24
*
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
12.3
25.0
45
37
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
5.6
24.9
74
136
X76
ICPC
Malignant neoplasm breast female
131.1
24.6
26
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
24.6
609
3939
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
24.6
148
513
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
18.7
24.3
37
20
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.5
24.2
88
202
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
8.0
24.2
55
70
N02BE01
ATC
paracetamol; systemic, rectal
1.6
24.0
2212
19622
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
10.4
24.0
47
46
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
24.0
23
*
L02BB03
ATC
bicalutamide; oral
+∞
24.0
23
*
2168A
ICD-9 Finland
Benign neoplasm of skin, Other specified sites of skin[IHON BEN KASV MUUALLA,NAEVUS PIGMENTOSUS]
+∞
24.0
23
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
15.2
23.7
39
26
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
126.0
23.6
25
*
L04AX01
ATC
azathioprine; systemic
2.8
23.3
156
579
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
17.3
23.1
36
21
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
22.9
22
*
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.1
22.9
266
1315
JN4CD
NOMESCO Finland
Very extensive body CT
5.7
22.8
66
118
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
231.7
22.6
23
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
231.7
22.6
23
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
22.6
456
2762
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
14.2
22.6
38
27
J01DB01
ATC
cefalexin; oral
1.6
22.4
2153
19064
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
45.4
22.4
27
6
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
10.1
22.3
44
44
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
21.9
21
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
21.9
21
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
21.9
21
*
Y77
ICPC
Malignant neoplasm prostate
63.0
21.9
25
*
Z51.5
ICD-10 Finland
Palliative care
5.9
21.7
61
105
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
221.6
21.6
22
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.7
21.5
73
157
A04AA01
ATC
ondansetron; systemic, rectal
3.7
21.4
96
268
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.8
21.2
138
503
N18.8
ICD-10 Finland
Other chronic renal failure
4.0
21.2
85
215
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.4
21.0
50
69
B01AB05
ATC
enoxaparin; parenteral
1.6
20.9
615
4146
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.8
20.9
89
238
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
20.9
20
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
20.7
220
1042
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
110.8
20.6
22
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
12.6
20.3
36
29
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
9.7
20.3
41
43
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.1
20.1
55
92
B03XA01
ATC
erythropoietin; parenteral
10.4
20.1
39
38
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.8
20.0
67
142
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
27.2
20.0
27
10
H02AB04
ATC
methylprednisolone; systemic
1.8
20.0
367
2153
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
57.9
19.9
23
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
57.9
19.9
23
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
36.0
19.8
25
7
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
19.8
19
*
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
+∞
19.8
19
*
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
+∞
19.8
19
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
19.8
19
*
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
+∞
19.8
19
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
19.8
19
*
C43.49
ICD-10 Finland
Malignant melanoma of the scalp and neck other or unspecified histology
+∞
19.8
19
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
19.8
19
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
19.8
19
*
V03AE02
ATC
sevelamer; oral
11.7
19.7
36
31
XKD00
NOMESCO Finland
Uroflowmetry
1.9
19.7
291
1579
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
105.7
19.6
21
*
Z51.0
ICD-10 Finland
Radiotherapy session
201.3
19.6
20
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
201.3
19.6
20
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
7.1
19.3
47
67
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
5.4
19.3
58
109
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
15.6
19.2
31
20
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
19.2
294
1616
WZC30
NOMESCO Finland
Teaching
2.0
19.0
246
1267
A02BC02
ATC
pantoprazole; systemic
1.4
19.0
1516
12642
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.7
18.8
133
511
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
+∞
18.8
18
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
18.8
18
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
18.8
18
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
18.8
18
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
18.8
18
*
C43.00
ICD-10 Finland
Malignant melanoma of the lip without histology
+∞
18.8
18
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
18.8
18
*
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
20.9
18.6
27
13
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
18.6
402
2477
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
18.6
992
7632
ZZA00
NOMESCO Finland
Split skin graft
4.0
18.5
75
192
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
191.1
18.5
19
*
C43.63
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder nodular
191.1
18.5
19
*
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
8.1
18.5
41
51
R50.9
ICD-10 Finland
Fever, unspecified
1.8
18.1
311
1778
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
6.6
17.9
46
71
TK820
NOMESCO Finland
Peritoneal dialysis
13.0
17.9
31
24
C43.82
ICD-10 Finland
Overall malignant melanoma of the skin: 'superficial spreading' type
+∞
17.7
17
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
17.7
17
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
17.6
799
5928
TQW20
NOMESCO Finland
Tatoe
36.9
17.6
22
6
196
Kela drug reimbursment
Paricalcitol and cinacalcet
11.5
17.5
32
28
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
7.9
17.3
39
50
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
17.0
186
893
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
11.6
17.0
31
27
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
16.9
116
439
J01MA02
ATC
ciprofloxacin; systemic
1.5
16.9
858
6508
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
22.0
16.8
24
11
ZXA00
NOMESCO Finland
Right side
1.6
16.8
569
3942
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
16.8
517
3502
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
63.7
16.7
19
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
16.7
16
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
16.7
16
*
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
16.7
16
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
16.7
16
*
8720/3-C44.4
ICD-O-3
Malignant melanoma, NOS, of skin of scalp and neck
+∞
16.7
16
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
90.6
16.6
18
*
ZZA50
NOMESCO Finland
Full thickness skin graft
23.2
16.4
23
10
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
16.4
131
540
ZXA05
NOMESCO Finland
Left side
1.6
16.4
534
3668
B01AB10
ATC
tinzaparin; parenteral
2.6
16.3
120
471
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
8.1
16.2
36
45
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
16.2
79
238
SPAT1325
SPAT
Vaccination
1.5
16.0
801
6039
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
16.0
310
1841
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
13.6
16.0
27
20
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
8.4
15.7
34
41
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
+∞
15.6
15
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
15.6
15
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
15.6
15
*
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
+∞
15.6
15
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
15.6
15
*
L01XE23
ATC
[U] dabrafenib; oral
+∞
15.6
15
*
C03CA01
ATC
furosemide; systemic
1.6
15.6
516
3551
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
15.6
424
2778
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
22.2
15.5
22
10
SPAT1301
SPAT
No procedures
1.5
15.4
759
5696
9733
FHL
Excision of skin change in operating room or anesthesia
5.0
15.3
49
100
UKC02
NOMESCO Finland
Cystoscopy
1.8
15.2
300
1791
N18.0
ICD-10 Finland
End-stage renal disease
5.7
15.1
43
77
Z94.1
ICD-10 Finland
Heart transplant status
14.0
15.0
25
18
C02AC05
ATC
moxonidine; oral
2.6
14.7
110
438
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
18.5
14.7
22
12
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.2
14.6
77
246
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
14.6
14
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
14.6
14
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
14.6
14
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
14.6
14
*
L01EC02
ATC
dabrafenib; oral
+∞
14.6
14
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
14.6
14
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
150.7
14.5
15
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
150.7
14.5
15
*
N63
ICD-10 Finland
Unspecified lump in breast
2.3
14.4
133
591
L02BG03
ATC
anastrozole; oral
15.4
14.4
23
15
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.6
14.4
64
180
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
14.3
618
4502
JN6AD
NOMESCO Finland
CT of torso and neck
11.4
14.3
26
23
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
22.4
14.2
20
9
HA1HA
NOMESCO Finland
Tomosynthesis mammography
22.4
14.2
20
9
L91.0
ICD-10 Finland
Hypertrophic scar
4.4
14.1
50
114
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
6.2
14.1
37
60
D22.0
ICD-10 Finland
Melanocytic naevi of lip
12.0
14.1
25
21
C08CA02
ATC
felodipine; oral
2.0
14.0
190
998
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
5.6
14.0
40
72
205
Kela drug reimbursment
Chronic hypertension
1.5
14.0
537
3812
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
14.0
279
1672
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
14.0
91
334
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
8.4
14.0
30
36
CBB30
NOMESCO Finland
Excision of lesion of eyelid
3.2
13.9
73
233
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
13.9
841
6538
S29
ICPC
Skin symptom/complaint other
1.6
13.9
374
2439
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
53.6
13.8
16
*
L03AB05
ATC
interferon alfa-2b; parenteral
23.9
13.8
19
8
D70.82
ICD-10 Finland
Drug-induced neutropenia
11.4
13.8
25
22
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
8.2
13.8
30
37
WX402
NOMESCO Finland
General anaesthesia
1.7
13.6
325
2055
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
13.5
13
*
C43.40
ICD-10 Finland
Malignant melanoma of the scalp and neck without histology
+∞
13.5
13
*
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
13.5
13
*
L02BG06
ATC
exemestane; oral
+∞
13.5
13
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
13.5
13
*
A79
ICPC
Malignancy NOS
140.6
13.5
14
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
6.1
13.4
36
60
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
13.4
421
2855
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
13.3
178
932
S15
ICPC
Foreign body in skin
2.1
13.3
145
698
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.4
13.2
645
4810
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
12.2
13.1
23
19
SPAT1263
SPAT
Sampling
1.4
13.0
1040
8459
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
13.0
170
881
XJH00
NOMESCO Finland
Transanal ultrasonography
2.4
13.0
110
471
-
ICD-10 Finland
NA
3.1
12.9
71
235
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.8
12.9
247
1461
R4180
NOMESCO Finland
Podiatric therapy
4.5
12.8
44
98
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
11.6
12.8
23
20
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
14.1
12.7
21
15
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
12.5
12
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
12.5
12
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
12.5
12
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
12.5
12
*
C43.90
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin without histology
+∞
12.5
12
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
12.5
12
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
12.5
12
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
12.5
12
*
L01EE01
ATC
trametinib; oral
+∞
12.5
12
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
8.7
12.5
26
30
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
130.5
12.4
13
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
130.5
12.4
13
*
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
130.5
12.4
13
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
130.5
12.4
13
*
V03AE01
ATC
polystyrene sulfonate; oral
4.8
12.4
40
84
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
12.2
715
5500
A98
ICPC
Health maint/preventive medicine
1.8
12.2
2636
25309
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.4
12.1
21
17
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
12.1
95
392
QXE99
NOMESCO Finland
Other excision or repair of unspecified region of skin
26.8
12.0
16
6
J05AB01
ATC
aciclovir; systemic
1.5
11.9
473
3371
R4110
NOMESCO Finland
Physiotherapy
1.5
11.9
522
3798
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.8
11.8
73
261
C08CA13
ATC
lercanidipine; oral
1.7
11.6
268
1674
Z3231
NOMESCO Finland
Registered nurse
1.4
11.5
583
4360
QBA10
NOMESCO Finland
Incision of skin of trunk
4.6
11.5
39
86
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.6
11.5
50
139
QXA05
NOMESCO Finland
Skin division, unspecified location
8.6
11.5
24
28
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
11.5
170
925
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
11.5
11
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
11.5
11
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
11.5
11
*
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
+∞
11.5
11
*
L01XE25
ATC
[U] trametinib; oral
+∞
11.5
11
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
11.5
11
*
2169A
ICD-9 Finland
Benign neoplasm of skin, Skin, site unspecified[IHON BEN KASV,NUD,NAEVUS PIGMENTOSUS]
+∞
11.5
11
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
11.5
11
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
11.5
11
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
11.5
11
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
11.5
11
*
L01AX03
ATC
temozolomide; systemic
+∞
11.5
11
*
L02AE02
ATC
leuprorelin; implant, parenteral
4.0
11.5
44
110
Z49.0
ICD-10 Finland
Preparatory care for dialysis
5.5
11.5
33
61
ZQZ00
NOMESCO Finland
Treatment of several skin areas
13.6
11.4
19
14
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
120.4
11.4
12
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
120.4
11.4
12
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
120.4
11.4
12
*
C90.0
ICD-10 Finland
Multiple myeloma
120.4
11.4
12
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
11.4
973
7957
ZX112
NOMESCO Finland
Subcutaneous
5.2
11.3
34
66
H02AB09
ATC
hydrocortisone; systemic
3.1
11.3
61
201
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
35.1
11.3
14
*
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
35.1
11.3
14
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
11.2
267
1685
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
11.2
223
1337
N02AA05
ATC
oxycodone; systemic
1.8
11.2
204
1190
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.5
11.2
32
59
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.9
11.1
44
113
G04BE03
ATC
sildenafil; oral
7.1
11.0
26
37
D02AE01
ATC
carbamide; topical
1.9
11.0
162
880
C02CA01
ATC
prazosin; oral
4.0
11.0
42
105
D06BX01
ATC
metronidazole; topical
1.7
10.9
247
1534
SPAT1260
SPAT
Consultation of another employee
1.5
10.9
410
2887
L02AE04
ATC
triptorelin; parenteral
43.5
10.9
13
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
10.9
276
1769
ZXD05
NOMESCO Finland
Urgent procedure
1.4
10.8
709
5544
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
8.3
10.8
23
28
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
10.8
158
855
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
10.8
111
523
WF004
NOMESCO Finland
Palliative radiotherapy
60.2
10.6
12
*
DAB10
NOMESCO Finland
Partial excision of auricle
60.2
10.6
12
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.9
10.6
164
906
J01CA04
ATC
amoxicillin; systemic
1.4
10.6
2093
19261
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
10.5
212
1274
A02BC05
ATC
esomeprazole; systemic
1.3
10.5
906
7393
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
10.5
862
6980
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.3
10.5
51
156
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
10.1
10.5
20
20
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
10.1
10.5
20
20
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
9.2
10.5
21
23
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
10.4
10
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
10.4
10
*
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
+∞
10.4
10
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
10.4
10
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
10.4
10
*
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
+∞
10.4
10
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
10.4
10
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
10.4
701
5504
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
10.3
525
3922
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
10.3
74
291
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
16.1
10.3
16
10
KAC10
NOMESCO Finland
Total nephrectomy with capsule
32.6
10.3
13
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
32.6
10.3
13
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.5
10.3
77
310
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
10.3
833
6732
L04AA05
ATC
[U] tacrolimus; systemic
18.8
10.2
15
8
J01FA10
ATC
azithromycin; systemic
1.3
10.2
1473
12914
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
23.4
10.2
14
6
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
23.4
10.2
14
6
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
10.2
386
2717
D07AC01
ATC
betamethasone; topical
1.3
10.2
777
6220
L72.1
ICD-10 Finland
Trichilemmal cyst
1.9
10.1
141
750
E000001
ATC
NA
1.4
10.1
470
3453
H05BX01
ATC
cinacalcet; oral
7.9
10.1
22
28
C07AG02
ATC
carvedilol; oral
2.1
10.1
113
553
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
8.5
10.0
21
25
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.3
10.0
49
151
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
14.6
10.0
16
11
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
10.0
945
7806
S21
ICPC
Skin texture symptom/complaint
1.6
9.9
253
1625
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
3.4
9.9
46
136
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
9.8
958
7945
V03AE03
ATC
lanthanum carbonate; oral
8.1
9.8
21
26
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
10.6
9.8
18
17
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
8.7
9.8
20
23
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
9.7
157
879
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.6
9.7
69
269
J05AB11
ATC
valaciclovir; oral
1.6
9.7
279
1844
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
4.3
9.7
34
79
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
9.7
207
1266
R01AD09
ATC
mometasone; nasal
1.3
9.5
1103
9357
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
9.5
89
401
DHB00
NOMESCO Finland
Excision of lesion of external nose
10.1
9.5
18
18
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
15.1
9.5
15
10
Z00.0
ICD-10 Finland
General medical examination
1.5
9.5
401
2891
SDA02
NOMESCO Finland
Parodonthologic therapy
1.3
9.4
783
6331
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
100.3
9.4
10
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
100.3
9.4
10
*
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
100.3
9.4
10
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
100.3
9.4
10
*
XX1XN
NOMESCO Finland
Other isotope examination
100.3
9.4
10
*
SPAT1324
SPAT
Screening procedure
1.4
9.4
471
3502
7151
FHL
Kidney transplantation
30.1
9.4
12
*
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
9.4
641
5031
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
9.4
9
*
1501
Kela drug reimbursment
Palbociclib
+∞
9.4
9
*
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
9.4
9
*
C43.89
ICD-10 Finland
Overall malignant melanoma of the skin other or unspecified histology
+∞
9.4
9
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
9.4
9
*
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
+∞
9.4
9
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
9.4
9
*
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
2.3
9.4
80
346
4056
NOMESCO Finland
NA
21.7
9.3
13
6
TPX15
NOMESCO Finland
Removal of vascular injection port
21.7
9.3
13
6
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
9.3
133
716
D06BX02
ATC
ingenol mebutate; topical
4.5
9.2
31
69
C03DA01
ATC
spironolactone; oral
1.7
9.2
201
1236
XW000
NOMESCO Finland
Bone marrow biopsy
2.7
9.2
60
225
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
7.7
9.1
20
26
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
3.8
9.1
37
99
TFJ02
NOMESCO Finland
Muscle biopsy of heart
8.3
9.1
19
23
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
9.0
493
3724
5AB14
NOMESCO Finland
NA
15.6
9.0
14
9
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
36.8
9.0
11
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
36.8
9.0
11
*
321
Kela drug reimbursment
Paricalcitol and cinacalcet
7.0
9.0
21
30
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
9.0
1260
10929
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
9.0
88
406
A02BC01
ATC
omeprazole; systemic
1.4
8.9
577
4480
PJA10
NOMESCO Finland
Exploration of lymph nodes
6.5
8.9
22
34
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
7.4
8.9
20
27
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.3
8.9
675
5376
H02AB06
ATC
prednisolone; systemic
1.3
8.9
1029
8702
ZX108
NOMESCO Finland
Inhalation
5.8
8.9
24
42
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
8.8
1631
14638
RS220
NOMESCO Finland
NA
3.7
8.8
36
97
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
8.8
140
784
A07AA02
ATC
nystatin; oral
2.0
8.8
116
606
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.6
8.7
38
108
D18.0
ICD-10 Finland
Haemangioma, any site
2.8
8.7
53
191
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
14.1
8.7
14
10
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
50.1
8.7
10
*
J01MA12
ATC
levofloxacin; systemic
1.5
8.6
335
2370
C08CA01
ATC
amlodipine; oral
1.3
8.6
668
5336
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.7
8.6
177
1072
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.1
8.6
93
451
Z94.2
ICD-10 Finland
Lung transplant status
11.6
8.6
15
13
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
10.0
8.5
16
16
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
90.3
8.4
9
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
90.3
8.4
9
*
C44.90
ICD-10 Finland
Unspecified localization of malignant tumor of the skin without histology
90.3
8.4
9
*
Z80.9
ICD-10 Finland
Family history of malignant neoplasm, unspecified
90.3
8.4
9
*
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
1.5
8.4
282
1934
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
8.4
1214
10541
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
4.5
8.3
28
63
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.3
8.3
40
123
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
+∞
8.3
8
*
C43.74
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip acral
+∞
8.3
8
*
394
Kela drug reimbursment
Palbociclib
+∞
8.3
8
*
C43.33
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face nodular
+∞
8.3
8
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
8.3
8
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
C43.80
ICD-10 Finland
Overall malignant melanoma of the skin without histology
+∞
8.3
8
*
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
8.3
8
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
8.3
8
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
8.3
8
*
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
+∞
8.3
8
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
8.3
8
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
8.3
8
*
D01AE16
ATC
amorolfine; topical
1.6
8.3
240
1589
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
10.8
8.3
15
14
WX110
NOMESCO Finland
Local anesthesy
1.3
8.2
1684
15237
C07AB02
ATC
metoprolol; systemic
1.4
8.2
382
2798
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
14.5
8.2
13
9
J02AC01
ATC
fluconazole; systemic
1.3
8.2
959
8101
-54
ICPC
Repair/fix-suture/cast/prosth device
2.6
8.2
57
223
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
5.7
8.1
22
39
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
8.1
169
1030
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
3.6
8.0
34
95
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
8.0
194
1231
S26
ICPC
Fear of cancer of skin
5.0
8.0
24
48
TDA10
NOMESCO Finland
Needle biopsy of auricle or external auditory canal
22.1
8.0
11
5
G04CA02
ATC
tamsulosin; oral
1.4
8.0
370
2707
DAB00
NOMESCO Finland
Excision of lesion of auricle
5.9
8.0
21
36
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
5.5
8.0
22
40
B35.3
ICD-10 Finland
Tinea pedis
2.1
7.9
86
417
C09CA01
ATC
losartan; oral
1.4
7.9
468
3575
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.2
7.9
40
128
D07AD01
ATC
clobetasol; topical
1.4
7.9
326
2334
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.6
7.9
225
1489
C10AA03
ATC
pravastatin; oral
1.8
7.9
132
753
N02AX02
ATC
tramadol; systemic, rectal
1.3
7.8
872
7309
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.6
7.8
55
217
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
10.8
7.8
14
13
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
7.0
7.8
18
26
C02EA02
ATC
NA
2.2
7.7
77
359
ZXC96
NOMESCO Finland
Robot assisted procedure
4.4
7.7
26
59
R31
ICD-10 Finland
Unspecified haematuria
1.7
7.7
158
957
ZZF00
NOMESCO Finland
Graft of adipose tissue
7.4
7.7
17
23
B02.9
ICD-10 Finland
Zoster without complication
1.9
7.6
99
517
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
18.4
7.6
11
6
QAE15
NOMESCO Finland
Excision of other superficial lesion of skin from head and neck
11.9
7.6
13
11
602
Kela drug reimbursment
Children's severe malnutrition
11.9
7.6
13
11
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
7.6
118
657
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.1
7.5
81
393
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.7
7.5
31
85
R22.7
ICD-10 Finland
Localized swelling, mass and lump, multiple sites
10.0
7.5
14
14
B35.1
ICD-10 Finland
Tinea unguium
1.8
7.4
121
684
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.8
7.4
121
684
SPAT1310
SPAT
Counselling related to known health issue
1.3
7.4
728
5995
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.0
7.4
93
482
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
7.3
7
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
7.3
7
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
7.3
7
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
7.3
7
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
C43.92
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin: 'superficial spreading' type
+∞
7.3
7
*
8743/3-C44.7
ICD-O-3
Low cumulative sun damage melanoma of skin of lower limb and hip
+∞
7.3
7
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
7.3
7
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
7.3
7
*
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
+∞
7.3
7
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
7.3
7
*
L01XE33
ATC
[U] palbociclib; oral
+∞
7.3
7
*
C43.41
ICD-10 Finland
Malignant melanoma of the scalp and neck originating in lentigo maligna
+∞
7.3
7
*
K50.8
ICD-10 Finland
Other Crohn disease
2.8
7.3
43
153
ZZR10
NOMESCO Finland
Flap of skin and muscle
10.9
7.3
13
12
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
9.4
7.3
14
15
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
9.4
7.3
14
15
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.5
7.3
31
88
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
7.2
137
814
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
4.3
7.2
25
59
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.7
7.2
47
179
C44
ICD-10 Finland
Other malignant neoplasms of skin
30.1
7.1
9
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
30.1
7.1
9
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
30.1
7.1
9
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
30.1
7.1
9
*
ZXA10
NOMESCO Finland
Bilateral
1.4
7.1
362
2695
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
20.1
7.1
10
5
9734
FHL
Excision and local plastic or associated free skin grafting
5.0
7.1
21
42
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.8
7.1
110
611
JFB30
NOMESCO Finland
Right hemicolectomy
6.0
7.1
18
30
ZXC20
NOMESCO Finland
Use of chemical agents
3.6
7.1
30
85
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.8
7.0
28
75
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.5
7.0
234
1605
Z2446
NOMESCO Finland
Social worker
1.7
7.0
128
752
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
7.0
143
866
Z94.4
ICD-10 Finland
Liver transplant status
7.0
7.0
16
23
L85.3
ICD-10 Finland
Xerosis cutis
4.0
7.0
26
66
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
5.2
6.9
20
39
Z3226
NOMESCO Finland
Physiotherapist
1.4
6.9
351
2611
J01DA01
ATC
[U] cefalexin; systemic
1.2
6.9
1508
13612
GDG10
NOMESCO Finland
Bilateral transplantation of lung
13.8
6.9
11
8
ZXE00
NOMESCO Finland
One hour or less
1.3
6.9
851
7206
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.8
6.9
116
666
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
3.8
6.8
27
72
C09AA02
ATC
enalapril; systemic
1.4
6.8
359
2689
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
6.8
233
1605
S19
ICPC
Skin injury other
2.0
6.8
82
417
R39.1
ICD-10 Finland
Other difficulties with micturition
2.4
6.8
55
235
M04AA01
ATC
allopurinol; systemic
1.5
6.8
198
1318
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
9.3
6.8
13
14
L85.89
ICD-10 Finland
Other specified epidermal thickening
9.3
6.8
13
14
HA1BA
NOMESCO Finland
Extensive X-ray mammography
9.3
6.8
13
14
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.8
77
381
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
6.8
505
3994
QDA10
NOMESCO Finland
Incision of skin of lower limb
4.5
6.8
22
49
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
40.1
6.8
8
*
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
40.1
6.8
8
*
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
40.1
6.8
8
*
J01EA01
ATC
trimethoprim; systemic
1.3
6.7
514
4079
R06AE07
ATC
cetirizine; oral
1.2
6.7
1013
8765
D75
ICPC
Malignant neoplasm colon/rectum
22.6
6.7
9
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
22.6
6.7
9
*
I78.1
ICD-10 Finland
Naevus, non-neoplastic
2.4
6.7
54
231
S59
ICPC
Skin, Other therap proced/minor surg NEC
3.3
6.6
31
95
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.9
6.6
85
444
WX002
NOMESCO Finland
Sedation and analgesia
1.4
6.6
370
2800
J01MA14
ATC
moxifloxacin; systemic
1.6
6.6
167
1074
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
2.2
6.6
62
285
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
2.5
6.6
48
195
TQW40
NOMESCO Finland
Remowal of suture of skin
1.7
6.6
129
772
QAA10
NOMESCO Finland
Incision of skin of head or neck
12.3
6.6
11
9
KC1GB
NOMESCO Finland
Cystography with X-ray
12.3
6.6
11
9
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
0.1
6.5
*
265
C03AA03
ATC
hydrochlorothiazide; oral
1.6
6.5
161
1030
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
6.5
332
2472
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.8
6.5
107
608
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
6.5
817
6919
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.0
6.5
19
38
K65.0
ICD-10 Finland
Acute peritonitis
3.8
6.5
25
66
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
6.4
1768
16292
D22.1
ICD-10 Finland
Melanocytic naevi of eyelid, including canthus
5.7
6.4
17
30
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
5.7
6.4
17
30
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
70.0
6.4
7
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
6.4
211
1440
R01AD12
ATC
fluticasone furoate; nasal
1.3
6.4
693
5759
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
7.4
6.4
14
19
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
14.3
6.4
10
7
J35.0
ICD-10 Finland
Chronic tonsillitis
1.7
6.4
127
765
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.2
6.4
30
93
L84
ICD-10 Finland
Corns and callosities
2.0
6.4
74
370
EMB10
NOMESCO Finland
Tonsillectomy
1.7
6.4
137
843
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
6.4
1118
9823
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
6.0
6.3
16
27
UJH02
NOMESCO Finland
Anoscopy
1.9
6.3
86
458
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
2.2
6.3
62
291
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
9.3
6.3
12
13
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
9.3
6.3
12
13
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.0
6.3
23
58
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
4.6
6.3
20
44
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
6.2
6
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
6.2
6
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
6.2
6
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
6.2
6
*
8743/3-C44.6
ICD-O-3
Low cumulative sun damage melanoma of skin of upper limb and shoulder
+∞
6.2
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.2
6
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
6.2
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.2
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.2
6
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
6.2
6
*
L01EF01
ATC
palbociclib; oral
+∞
6.2
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.2
6
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
6.2
6
*
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
+∞
6.2
6
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.2
6
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
6.2
6
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
6.2
6
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
6.2
6
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
6.2
6
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
+∞
6.2
6
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
6.2
6
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.2
6
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
6.2
6
*
C43.4
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of scalp and neck
+∞
6.2
6
*
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
2.9
6.2
36
126
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
2.7
6.2
38
140
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
6.2
281
2049
WX702
NOMESCO Finland
Supraglottic ventilation device
1.8
6.2
101
571
TKE10
NOMESCO Finland
Puncture of prostate
26.7
6.2
8
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
6.2
282
2055
D23.0
ICD-10 Finland
Benign neoplasm: Skin of lip
7.0
6.2
14
20
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.8
6.2
95
527
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.5
6.2
242
1714
N43.3
ICD-10 Finland
Hydrocele, unspecified
2.8
6.2
37
135
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
6.3
6.2
15
24
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.7
6.1
115
684
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.3
6.1
53
234
L01BB01
ATC
NA
7.7
6.1
13
17
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
6.1
643
5327
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.7
6.1
38
143
B02AA02
ATC
tranexamic acid; systemic
1.4
6.1
323
2423
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
6.0
346
2630
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
2.1
6.0
63
305
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
1860
8626
3.87
298.11
3.0
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
712
2171
3.95
202.55
1.7
1.1
—
—
—
0
0
(4035726)
379
773
5.44
178.45
1.6
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
157
132
12.47
157.02
1.2
1.6
ug/l
6.4
8.8
0.73
151
107
(3026250) Tacrolimus [Mass/volume] in Blood
105
91
11.91
102.74
45.6
35.1
ug/l
7.0
7.8
2.56
93
85
(3010375) cycloSPORINE [Mass/volume] in Blood
101
95
10.95
93.58
30.0
23.7
ug/l
95.6
121.7
2.48
84
77
(3013650) Neutrophils [#/volume] in Blood by Automated count
1887
13424
2.03
77.22
10.9
6.7
e9/l
4.0
4.1
2.44
1723
11646
(40760892) CBC W Ordered Manual Differential panel - Blood
993
5716
2.08
72.63
6.7
4.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1588
11035
1.90
65.10
7.6
3.9
umol/l
10.7
11.3
1.45
1522
10326
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2271
17988
1.97
59.59
10.3
5.5
u/l
73.9
74.4
0.20
2166
16775
(3024561) Albumin [Mass/volume] in Serum or Plasma
1345
9105
1.84
57.59
6.8
3.9
g/l
36.4
36.3
0.23
1273
8399
(3001604) Monocytes [#/volume] in Blood
1681
12187
1.82
57.37
8.0
5.6
e9/l
0.5
0.6
9.04
1534
10604
(3006315) Basophils [#/volume] in Blood
1683
12242
1.81
56.44
8.0
5.6
e9/l
0.0
0.0
0.14
1536
10646
(3019198) Lymphocytes [#/volume] in Blood
1718
12606
1.81
55.64
8.0
5.6
e9/l
1.9
1.9
0.05
1591
11176
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
434
1991
2.37
54.21
6.3
3.1
u/l
231.2
229.7
0.07
424
1862
(3013115) Eosinophils [#/volume] in Blood
1718
12683
1.79
53.74
8.1
5.8
e9/l
0.2
0.2
6.33
1591
11215
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
150
380
4.10
52.98
11.7
5.6
iu/ml
2772.7
596.0
0.75
38
50
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1496
10710
1.76
51.05
10.6
5.5
mmol/l
1.2
1.2
0.02
1263
9076
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
272
1034
2.79
50.09
3.6
1.6
ug/l
5.1
5.2
0.02
206
755
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1364
9596
1.75
48.77
5.2
3.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
545
2905
2.06
46.39
9.7
5.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1468
10659
1.71
45.93
4.2
3.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
507
2653
2.09
45.27
12.0
5.6
mmol/l
1.1
1.0
4.03
489
2471
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
118
287
4.23
43.98
4.2
2.7
u/ml
148.7
679.9
—
6
17
(3029937) Albumin [Presence] in Urine by Test strip
994
6582
1.75
42.59
5.8
3.6
estimate
0.0
0.0
0.04
320
2210
(3020779) Urea [Moles/volume] in Serum or Plasma
372
1772
2.25
42.00
17.6
7.5
mmol/l
10.9
9.4
3.57
367
1691
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1389
10123
1.67
41.41
2.7
2.2
nmol/l
77.8
76.2
1.44
1296
9170
(40768793) Breast Pathology biopsy report
91
198
4.70
39.04
1.3
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1603
12295
1.63
37.76
6.4
4.5
estimate
0.0
0.0
0.80
326
2256
(3009261) Glucose [Presence] in Urine by Test strip
1616
12420
1.63
37.74
5.1
3.3
estimate
0.0
0.0
1.32
318
2183
(3012095) Magnesium [Moles/volume] in Serum or Plasma
548
3128
1.91
37.64
5.4
2.8
mmol/l
0.8
0.8
0.07
522
2898
(40761535) Cells panel - Urine sediment
382
1918
2.13
37.61
5.6
3.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1597
12277
1.62
36.96
5.0
3.3
estimate
0.0
0.0
0.50
312
2188
(3019150) Specific gravity of Urine by Refractometry
838
5473
1.73
36.71
5.4
3.7
kg/l
1.0
1.0
1.42
87
796
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1305
9590
1.62
36.07
9.3
5.1
mmol/l
1.2
1.2
0.42
1207
8576
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
32
24
13.46
33.97
4.3
1.0
u/ml
23.0
16.5
0.86
32
24
(3018418) pH of Serum or Plasma
912
6200
1.67
33.91
7.5
3.2
ph
7.4
7.4
1.56
194
1068
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
241
1042
2.42
33.83
1.6
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1426
10859
1.58
32.94
12.3
7.9
e9/l
0.0
0.0
0.34
1227
8883
(3019550) Sodium [Moles/volume] in Serum or Plasma
2851
25943
2.16
32.06
19.2
12.4
mmol/l
139.8
139.7
0.47
2798
25249
(3017181) Myelocytes/100 leukocytes in Blood
355
1842
2.05
31.79
5.5
4.1
%
1.0
0.6
1.85
96
372
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2820
25590
2.07
31.42
17.2
11.0
mg/l
19.9
21.4
1.62
2261
19571
(40768443) Skin Pathology biopsy report
212
896
2.47
31.24
1.2
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
239
1070
2.34
30.97
4.4
2.5
e6/l
0.2
0.2
0.07
233
1034
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
318
1601
2.10
30.85
6.8
3.8
ng/l
124.4
85.2
4.93
286
1401
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1014
7214
1.60
30.79
3.8
2.4
u/l
58.2
58.3
0.02
951
6662
(3000850) Epithelial cells [#/volume] in Urine
710
4651
1.68
29.83
3.9
2.4
e6/l
4.5
6.5
3.82
648
4038
(3023103) Potassium [Moles/volume] in Serum or Plasma
2850
26050
2.10
29.74
19.4
12.5
mmol/l
4.0
4.0
0.06
2792
25307
(3036481) Cortisol [Moles/volume] in Serum or Plasma
404
2244
1.92
29.65
3.3
1.8
nmol/l
365.0
365.8
0.03
381
2049
(3015377) Calcium [Moles/volume] in Serum or Plasma
983
7019
1.58
29.02
4.1
2.0
mmol/l
2.3
2.4
0.26
891
6026
(3021440) Promyelocytes/100 leukocytes in Blood
338
1779
2.01
28.98
5.6
4.2
%
0.1
0.1
0.92
87
346
(3002385) Erythrocyte distribution width [Ratio]
2468
21691
1.66
28.23
19.9
13.2
%
13.6
13.5
0.90
2437
21173
(3025159) Blasts/100 leukocytes in Blood
325
1704
2.01
28.14
5.7
4.2
%
0.1
0.3
0.48
76
301
(3013826) Glucose [Moles/volume] in Serum or Plasma
1687
13648
1.51
27.65
5.9
4.2
mmol/l
6.5
6.6
0.93
1582
12579
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
148
557
2.74
27.62
6.8
3.3
mg/l
1.7
1.4
2.67
140
511
(40768795) Lymph node Pathology biopsy report
38
50
7.68
27.19
1.2
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2918
27081
2.21
26.50
16.8
10.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
454
2724
1.78
25.82
2.0
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
859
6089
1.57
25.54
4.3
2.8
e6/l
0.3
0.4
1.14
715
4542
(3026782) Osmolality of Urine
640
4232
1.64
25.42
4.6
2.5
mosm/kgh2o
527.6
550.2
1.81
578
3560
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
31
35
8.94
25.07
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
317
1716
1.94
24.95
5.0
3.9
%
0.6
0.4
0.92
65
284
(40768446) Kidney Pathology biopsy report
49
93
5.34
24.66
2.1
1.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1904
15992
1.49
24.61
5.0
4.0
e6/l
292.9
2064.2
2.26
30
194
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2929
27325
2.19
24.55
20.6
12.2
umol/l
81.7
74.7
13.40
2929
27313
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2940
27498
2.22
23.97
13.2
8.4
u/l
25.7
26.2
0.67
2872
26521
(3014576) Chloride [Moles/volume] in Serum or Plasma
416
2486
1.78
23.87
7.6
6.5
mmol/l
104.4
104.4
0.00
410
2421
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
116
415
2.86
23.83
1.5
1.4
u/l
26.2
23.7
0.36
98
329
(3035637) Corticotropin [Mass/volume] in Plasma
80
229
3.56
23.79
1.6
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
321
1778
1.90
23.53
1.2
1.3
u/ml
124.4
222.1
2.23
301
1651
(3044889) 12 lead EKG panel
2004
17082
1.48
23.48
4.3
3.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2159
18692
1.50
23.34
5.1
3.9
mm/h
11.0
10.5
0.80
2027
17394
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
26
26
10.08
22.94
8.1
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
44
81
5.50
22.89
6.2
5.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1128
8660
1.47
22.32
3.9
3.3
ng/l
45.3
64.9
0.80
751
5291
(3032080) INR in Blood by Coagulation assay
1112
8522
1.47
22.16
9.9
8.5
inr
1.2
1.2
2.09
359
2600
(36304419) Bacteria [Presence] in Urine
828
6018
1.51
21.27
4.0
2.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
900
6673
1.49
20.92
4.9
2.9
e6/l
35.0
74.5
1.70
760
5067
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
28
35
8.06
20.89
5.7
5.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
894
6629
1.49
20.74
3.3
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
108
403
2.74
20.53
6.1
2.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
847
6248
1.49
20.03
3.6
2.2
umol/l
4358.6
4414.8
0.01
760
5449
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
254
1373
1.93
19.98
1.7
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
320
1864
1.80
19.87
3.2
2.2
ml/min/173m2
55.7
70.1
7.49
159
699
(3018095) Leukocytes [#/volume] in Urine
1056
8146
1.45
19.78
5.2
3.3
e6/l
90.5
91.9
0.01
848
5535
(3023368) Bacteria identified in Blood by Culture
730
5246
1.51
19.53
4.9
3.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
289
1642
1.84
19.46
6.6
2.8
mmol/l
1.2
1.2
0.02
258
1384
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2287
20324
1.47
19.27
4.8
3.9
pmol/l
14.8
14.6
5.54
2135
18734
(3007461) Platelets [#/volume] in Blood
3037
29064
2.75
19.01
25.7
16.2
e9/l
251.6
254.9
2.09
3001
28322
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
86
296
2.96
18.99
2.0
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
3038
29084
2.76
18.89
25.6
16.2
fl
90.7
90.6
0.25
3017
28683
(3035941) MCH [Entitic mass]
3038
29084
2.76
18.89
25.6
16.2
pg
30.2
30.2
0.08
3017
28681
(3022096) Basophils/100 leukocytes in Blood
1354
10990
1.41
18.86
8.2
5.8
%
0.7
0.7
0.56
1289
10217
(3026361) Erythrocytes [#/volume] in Blood
3038
29090
2.75
18.77
25.7
16.2
e12/l
4.5
4.5
3.28
2991
28274
(3019069) Monocytes/100 leukocytes in Blood
1399
11431
1.41
18.69
8.4
6.0
%
8.4
8.4
0.28
1338
10685
(3010813) Leukocytes [#/volume] in Blood
3038
29094
2.74
18.69
25.8
16.3
e9/l
6.6
6.7
0.97
2989
28270
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
442
2860
1.64
18.64
4.6
2.6
%
24.1
23.9
0.09
389
2433
(3000963) Hemoglobin [Mass/volume] in Blood
3038
29099
2.74
18.59
25.8
16.3
g/l
135.8
136.8
3.98
3018
28690
(3006504) Eosinophils/100 leukocytes in Blood
1390
11356
1.40
18.53
8.2
5.7
%
2.8
2.9
1.19
1324
10546
(42870588) Differential panel, method unspecified - Blood
1013
7838
1.43
18.34
7.4
5.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
539
3671
1.57
18.32
3.2
2.5
e6/l
1.7
1.1
0.38
369
2052
(3002030) Lymphocytes/100 leukocytes in Blood
1434
11811
1.40
18.06
8.2
5.8
%
28.7
28.9
0.31
1365
10999
(3011397) Hemoglobin [Presence] in Urine by Test strip
779
5750
1.47
18.05
5.2
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
121
510
2.43
17.96
1.5
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
509
3446
1.57
17.71
4.3
2.4
umol/l
13.8
13.9
0.14
486
3173
(3004789) Transferrin [Mass/volume] in Serum or Plasma
471
3132
1.59
17.70
4.4
2.4
g/l
2.3
2.4
0.95
455
2897
(3037467) Urinalysis macro (dipstick) panel - Urine
1972
17176
1.40
17.60
5.2
3.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
74
245
3.07
17.51
1.9
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
117
494
2.42
17.31
4.2
3.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2611
23994
1.54
17.27
5.6
4.6
mu/l
1.9
2.0
0.84
2472
22283
(3024354) Oxygen [Partial pressure] in Venous blood
277
1616
1.78
17.05
5.6
2.9
kpa
4.9
4.6
1.09
270
1554
(3020891) Body temperature
166
819
2.08
16.88
6.5
4.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
253
1445
1.82
16.71
1.4
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1409
11696
1.37
16.33
7.9
5.6
%
57.3
56.8
0.91
1346
10923
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
89
339
2.67
16.32
1.4
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
317
1946
1.70
16.28
6.3
3.5
kpa
5.8
5.9
0.27
310
1877
(3030905) Polymorphonuclear cells [#/volume] in Blood
104
429
2.47
16.20
3.4
3.3
e9/l
3.8
4.1
1.00
104
429
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
924
7158
1.41
16.18
2.4
2.1
u/l
145.6
232.0
3.07
878
6734
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
105
437
2.45
16.05
3.9
3.5
%
56.4
57.1
0.27
105
437
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
28
47
6.00
16.04
6.3
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
778
5853
1.44
16.01
3.7
2.9
ng/l
1457.0
1219.9
0.70
679
4908
(40758558) Short blood count panel - Blood
756
5665
1.44
15.88
8.0
4.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
881
6790
1.41
15.82
4.2
2.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
46
120
3.88
15.73
1.3
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
313
1935
1.69
15.64
6.4
3.6
mmol/l
1.7
2.0
0.69
259
1563
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
182
959
1.95
15.42
4.6
2.5
%
0.7
0.6
0.13
176
916
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
338
2145
1.65
15.27
3.8
2.9
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
187
1001
1.92
15.13
1.9
1.5
u/ml
53.3
24.0
0.95
179
957
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
102
432
2.41
15.03
1.9
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
103
439
2.39
14.96
1.9
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1388
11606
1.35
14.85
3.7
2.8
ug/l
116.6
100.7
1.85
1317
10853
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
31
62
5.04
14.77
3.4
3.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
104
449
2.36
14.69
2.1
1.4
u/ml
103.3
106.4
0.15
26
84
(3000494) Fungus identified in Specimen by Culture
417
2810
1.56
14.63
1.8
1.4
—
—
—
0
0
(3012544) pH of Venous blood
320
2024
1.65
14.63
6.4
3.6
—
7.4
—
0
7
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
43
113
3.84
14.57
2.7
2.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
470
3275
1.51
14.11
2.4
2.0
s
29.3
29.7
0.69
453
3166
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
24
40
6.04
13.85
1.5
2.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
73
274
2.70
13.82
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
470
3297
1.50
13.64
2.8
2.4
ug/g
127.0
119.2
0.17
393
2614
(3008152) Bicarbonate [Moles/volume] in Arterial blood
217
1258
1.78
13.63
7.2
7.2
mmol/l
24.4
24.6
0.30
205
1160
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
210
1209
1.79
13.50
1.6
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
76
297
2.60
13.30
2.4
2.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
106
483
2.24
13.23
2.2
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
255
1561
1.69
13.19
2.0
2.2
nmol/l
12.9
13.4
0.45
236
1388
(3002173) Hemoglobin [Mass/volume] in Arterial blood
290
1836
1.64
13.18
6.6
8.4
g/l
120.4
123.7
1.79
278
1763
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
269
1671
1.67
13.17
2.5
2.2
g/l
0.2
0.2
1.71
257
1536
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
116
550
2.15
13.13
3.3
3.9
u/ml
0.3
0.4
2.33
66
312
(3022145) Colonoscopy Study observation
366
2464
1.55
12.83
1.4
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
43
124
3.50
12.77
2.4
2.2
%
17.7
12.8
0.75
15
61
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
134
680
2.01
12.68
2.2
1.8
ug/l
2.1
1.8
0.14
129
594
(3016502) Oxygen saturation in Arterial blood
306
1983
1.60
12.64
6.4
8.1
%
96.2
95.4
1.39
295
1905
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
43
125
3.47
12.62
2.3
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
51
166
3.11
12.51
2.5
2.5
e9/l
1.1
1.2
0.82
38
89
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
341
2275
1.56
12.43
1.9
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
339
2260
1.56
12.40
1.8
1.7
—
—
—
0
0
(3013512) EKG study
814
6414
1.36
12.23
4.6
3.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
853
6772
1.36
12.21
2.6
2.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
105
495
2.16
12.08
2.1
1.4
—
20.4
—
0
14
(3005719) IgG [Mass/volume] in Serum or Plasma
267
1696
1.63
11.96
3.4
2.3
g/l
10.1
10.7
1.57
257
1552
(3020630) Protein [Mass/volume] in Serum or Plasma
252
1578
1.65
11.95
3.2
1.5
g/l
65.8
67.4
2.71
236
1436
(3042936) Bacteria identified in Isolate by Culture
431
3050
1.48
11.88
2.4
2.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
11
0
+∞
11.46
1.0
0.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
328
2211
1.54
11.39
6.2
7.7
mmol/l
1.0
1.2
0.31
246
1689
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2650
24883
1.43
11.34
5.1
4.2
mmol/l
5.8
5.9
1.51
2474
22992
(21494814) CD8 cells/100 lymphocytes in Specimen
27
61
4.46
11.19
1.3
2.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
53
189
2.84
11.11
2.0
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
95
446
2.17
11.08
6.0
3.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
209
1274
1.69
10.99
4.6
5.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
328
2228
1.53
10.99
6.2
7.6
kpa
5.1
5.1
0.17
311
2125
(3027801) Oxygen [Partial pressure] in Arterial blood
328
2228
1.53
10.99
6.2
7.6
kpa
12.4
12.1
0.64
312
2121
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2559
23929
1.39
10.81
15.5
9.7
ml/min/173m2
81.7
84.8
9.30
2177
19276
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
975
8016
1.31
10.71
3.7
2.7
u/l
28.3
34.3
1.97
928
7612
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
247
1583
1.61
10.67
3.9
3.1
pmol/l
4.5
4.5
0.10
229
1401
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
619
4761
1.37
10.63
1.6
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
85
390
2.21
10.51
3.1
2.3
u/ml
314.8
83.4
0.36
70
311
(3023520) Reticulocytes [#/volume] in Blood
248
1607
1.59
10.24
2.4
2.4
e9/l
70.8
70.0
0.12
200
1209
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
40
130
3.10
9.90
5.3
1.1
u/ml
263.6
149.7
0.20
12
31
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2715
25731
1.43
9.87
4.9
4.2
mmol/l
4.6
4.7
4.18
2579
24197
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
446
3302
1.41
9.55
2.0
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
252
1667
1.56
9.52
9.2
8.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
100
508
2.00
9.51
1.5
1.2
u/ml
280.0
248.7
0.49
80
320
(3004775) Volume in Urine collected for unspecified duration
49
184
2.69
9.38
3.7
2.4
ml
773.9
624.0
1.43
41
130
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
44
156
2.85
9.37
1.9
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
44
156
2.85
9.37
1.9
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
44
156
2.85
9.37
1.9
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2744
26102
1.43
9.33
5.3
4.6
mmol/l
2.7
2.8
4.51
2576
24413
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
53
208
2.57
9.30
1.8
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
418
3075
1.42
9.27
2.1
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
31
90
3.47
9.19
1.1
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
450
3368
1.39
9.02
3.8
2.6
e6/l
2.7
3.0
0.26
280
1758
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
75
349
2.18
9.01
1.8
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
109
582
1.90
8.99
3.2
2.9
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
15
24
6.28
8.99
2.8
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
113
612
1.88
8.93
5.1
4.1
mmol/l
3.9
3.9
0.12
107
571
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
60
255
2.38
8.91
2.1
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
203
1297
1.60
8.90
2.9
2.1
u/l
5805.8
5741.8
0.01
86
527
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
102
535
1.94
8.88
1.4
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
836
6874
1.30
8.86
5.1
3.6
ug/l
2.3
2.4
0.08
757
6218
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
191
1205
1.62
8.82
7.9
9.5
%
0.7
0.7
1.33
191
1196
(44790047)
56
233
2.43
8.72
2.0
1.4
—
—
—
0
0
(44806118)
56
233
2.43
8.72
2.0
1.4
—
—
—
0
0
(44790049)
56
233
2.43
8.72
2.0
1.4
—
—
—
0
0
(44790048)
56
233
2.43
8.72
2.0
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
731
5918
1.31
8.68
2.5
2.2
mg/l
2.8
2.8
0.26
666
5038
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2612
24704
1.35
8.67
4.5
3.8
mmol/l
1.3
1.3
1.16
2445
23001
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1122
9595
1.26
8.62
1.8
1.9
pmol/l
98.7
96.3
0.87
590
4998
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
484
3700
1.36
8.49
2.9
2.0
mmol/l
2.4
2.4
0.09
428
3166
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
118
660
1.82
8.44
3.3
2.7
g/l
3.4
3.6
0.64
111
617
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
190
1214
1.60
8.35
7.9
9.4
%
1.4
1.4
0.01
190
1208
(3009214) Lutropin [Units/volume] in Serum or Plasma
129
745
1.76
8.30
1.4
1.3
u/l
10.3
9.5
0.31
111
616
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
167
1035
1.65
8.30
1.6
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
204
1329
1.57
8.26
2.2
1.5
g/l
1.2
1.2
0.03
192
1220
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
47
185
2.56
8.24
1.9
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2476
23302
1.30
8.03
6.4
5.3
mmol/mol
39.1
39.2
0.15
2335
21844
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
144
867
1.69
8.00
2.3
1.7
g/l
1.4
1.5
0.86
136
747
(3049717) Cytology report of Urine Cyto stain
107
594
1.83
7.87
2.7
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2686
25596
1.36
7.81
4.9
4.1
mmol/l
1.5
1.5
0.65
2526
23957
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
333
2.10
7.61
2.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
840
7023
1.27
7.60
1.5
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
81
415
1.98
7.60
3.8
2.3
%
16.3
16.8
0.47
50
206
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
14
25
5.62
7.54
1.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
51
218
2.36
7.53
3.6
2.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
679
5536
1.29
7.51
4.7
3.5
%
92.4
91.7
0.28
661
5374
(3007930) Methemoglobin/Hemoglobin.total in Blood
136
821
1.69
7.50
4.2
5.6
%
0.9
0.9
0.23
130
769
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
76
384
2.00
7.42
1.3
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
159
1006
1.61
7.31
1.3
1.3
miu/ml
219.3
229.2
0.13
73
501
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
29
94
3.10
7.28
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
85
450
1.91
7.26
6.1
3.9
mmol/l
2.4
2.5
0.05
56
292
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
734
6088
1.27
7.01
1.3
1.3
u/ml
1.2
1.9
1.35
238
1668
(3021901) Oxygen saturation in Capillary blood
70
351
2.02
7.00
4.1
2.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
27
5.20
6.97
17.8
9.2
mmol/l
4.9
6.3
0.96
14
27
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
134
826
1.65
6.85
4.3
5.4
%
1.4
1.7
3.90
128
772
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
100
570
1.78
6.79
4.1
2.4
ug/min
95.1
96.9
0.02
73
365
(3020682) Albumin/Creatinine [Ratio] in Urine
848
7177
1.25
6.78
5.3
4.0
mg/mmol
15.9
8.4
2.34
579
4585
(3027945) Reticulocytes/100 erythrocytes in Blood
302
2216
1.40
6.77
3.2
2.4
%
1.8
1.7
0.53
285
1951
(3037756) Immunofixation for Serum or Plasma
63
308
2.07
6.76
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
122
737
1.68
6.74
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
122
742
1.67
6.58
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
123
750
1.67
6.57
1.3
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
25
79
3.18
6.56
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
139
877
1.61
6.49
1.5
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
556
4497
1.29
6.46
2.0
1.7
—
—
—
0
0
(3010421) pH of Blood
95
542
1.78
6.45
5.7
3.8
ph
7.4
7.4
0.65
84
447
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
111
668
1.69
6.25
3.6
2.4
%
168.7
177.0
0.46
103
636
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
19
5.81
6.10
1.3
2.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
36
145
2.50
6.10
2.7
2.4
e6/l
705.5
815.8
0.29
11
64
(3037692) Legionella sp identified in Specimen by Organism specific culture
21
63
3.35
5.99
2.6
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
170
1150
1.51
5.87
2.1
2.3
—
—
—
0
0
(3024471) HLA-A [Type]
24
80
3.02
5.80
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
34
137
2.50
5.77
1.3
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
253
1854
1.40
5.73
1.9
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
161
1083
1.51
5.72
1.3
1.3
u/ml
0.2
0.9
1.88
15
92
(3012516) Albumin [Mass/volume] in Urine
799
6843
1.23
5.55
4.3
3.3
mg/l
569.6
253.7
0.89
538
4344
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1952
18167
1.20
5.53
3.3
3.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
662
5562
1.24
5.51
2.1
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
650
5451
1.24
5.50
1.5
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
29
111
2.63
5.47
3.6
2.7
%
44.0
45.7
—
5
40
(3000570) Elastase.pancreatic [Mass/mass] in Stool
98
593
1.67
5.45
1.4
1.4
ug/g
292.1
308.5
0.33
56
314
(3000330) Specific gravity of Urine by Test strip
167
1146
1.48
5.40
4.9
3.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
240
1768
1.39
5.28
7.3
6.9
mmol/l
1.3
1.4
1.03
225
1707
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
32
131
2.46
5.28
1.7
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
22
75
2.95
5.14
3.2
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
68
379
1.81
5.06
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
654
5533
1.23
5.06
4.8
3.5
%
22.8
23.9
1.11
354
2451
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
118
769
1.56
4.89
1.3
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
48
241
2.01
4.89
1.9
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
71
406
1.77
4.87
1.2
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
94
581
1.64
4.86
1.7
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
348
2747
1.30
4.84
22.6
23.7
inr
1.2
1.3
1.35
30
410
(3015235) Bicarbonate [Moles/volume] in Capillary blood
85
513
1.68
4.82
4.7
3.1
mmol/l
24.5
24.9
0.36
80
450
(21494890) Protein electrophoresis panel - 24 hour Urine
36
163
2.22
4.78
2.0
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
252
1904
1.35
4.76
2.5
2.3
ug/l
8.0
7.8
0.05
231
1699
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
16
47
3.42
4.74
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
251
1.97
4.73
1.3
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
649
5522
1.22
4.73
2.1
1.8
mg/l
1.0
1.0
0.09
507
4132
(3009508) Creatinine [Moles/volume] in Urine
864
7562
1.20
4.68
4.1
3.2
mmol/l
7.2
7.8
4.13
770
6476
(3004588) Protein electrophoresis panel - Serum or Plasma
184
1328
1.41
4.60
2.3
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
67
384
1.76
4.58
3.0
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
37
173
2.15
4.56
1.3
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
113
743
1.54
4.53
2.9
2.2
%
93.4
92.8
0.09
101
693
(3004451) EKG impression Narrative
24
93
2.59
4.47
1.1
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
609
5176
1.22
4.46
1.9
1.3
g/l
2.2
2.4
1.01
427
3196
(3000060) B lymphocytes [#/volume] in Blood
15
44
3.42
4.46
3.9
2.1
e6/l
163.0
154.3
—
10
28
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
40
195
2.06
4.44
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
264
2031
1.33
4.43
6.6
3.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
22
83
2.66
4.32
1.0
1.1
%
85.3
89.0
0.21
12
40
(3003338) MCHC [Mass/volume]
2382
22763
1.20
4.31
21.4
14.1
g/l
332.9
332.9
0.03
2372
22604
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
54
298
1.83
4.21
1.6
1.4
pmol/l
243.2
302.2
1.08
39
230
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
24
96
2.51
4.21
1.4
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
68
403
1.70
4.17
1.3
1.5
nmol/l
0.5
0.4
0.17
50
345
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
603
5158
1.21
4.12
2.5
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
53
294
1.82
4.08
1.7
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
76
467
1.64
4.08
3.3
2.1
g/l
127.3
133.3
1.56
61
342
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
39
196
2.00
4.02
1.3
1.1
u/l
65.3
58.4
0.24
26
135
(3019309) Folate [Moles/volume] in Red Blood Cells
487
4088
1.23
4.02
1.7
1.7
nmol/l
1321.9
1154.9
3.95
400
3116
(3000034) Microalbumin [Mass/volume] in Urine
42
217
1.95
4.01
3.0
3.1
mg/l
68.1
28.0
0.37
30
156
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
26
111
2.35
3.99
1.5
1.7
nmol/l
1.5
5.6
1.12
21
85
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
21
81
2.60
3.97
1.0
1.1
%
89.6
88.8
0.03
11
39
(3001964) Herpes simplex virus Ag [Presence] in Specimen
18
64
2.82
3.95
2.1
1.3
—
—
—
0
0
(4010399)
224
1713
1.33
3.94
1.6
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
21
82
2.57
3.88
1.4
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
54
308
1.77
3.81
1.3
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
49
3.07
3.80
1.5
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
64
384
1.68
3.78
1.4
1.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
8
8.77
3.77
8.6
6.5
—
—
—
0
0
(4062490)
47
258
1.83
3.76
1.9
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
20
78
2.57
3.71
1.7
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
45
246
1.84
3.66
1.7
1.3
—
—
—
0
0
(3036489) Thrombin time
126
889
1.43
3.64
2.7
2.0
s
21.6
20.9
0.65
113
758
(21494755) Public health laboratory ask at order entry panel
244
3081
0.77
3.61
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
551
4730
1.20
3.61
1.3
1.3
iu/ml
20.5
29.2
1.77
172
1462
(3035947) Staphylolysin Ab [Units/volume] in Serum
24
104
2.32
3.59
1.3
1.1
—
4.4
—
0
9
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
109
751
1.47
3.57
1.8
1.7
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
138
997
1.40
3.50
1.7
1.7
u/ml
12.0
20.3
—
6
28
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
110
763
1.46
3.49
2.5
2.4
ug/l
514.6
741.6
0.28
101
706
(3047352) Trisomy 18 risk [Likelihood] in Fetus
42
739
0.56
3.48
1.2
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
20
81
2.48
3.46
1.6
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
80
520
1.55
3.46
3.2
1.5
mg/l
38.8
43.4
0.13
60
417
(3005033) Fetal Nuchal fold Thickness US
42
735
0.57
3.42
1.2
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
56
334
1.69
3.42
1.3
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
80
522
1.55
3.40
3.2
1.5
mg/l
61.3
44.2
1.09
58
419
(3043238) Trisomy 21 risk [Likelihood] in Fetus
44
758
0.57
3.38
1.3
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
166
1245
1.35
3.37
5.4
3.2
mmol/l
1.5
1.7
0.15
118
897
(3021879) Hepatitis B virus core Ab [Presence] in Serum
247
1961
1.28
3.34
1.6
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
55
330
1.68
3.29
1.4
1.4
mmol/l
54.4
66.4
1.91
42
272
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
140
1028
1.38
3.25
6.7
11.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
64
401
1.61
3.25
1.3
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
287
2330
1.26
3.23
2.0
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
62
967
0.63
3.20
1.8
2.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
189
1457
1.32
3.20
1.3
1.3
iu/l
26.2
27.3
0.18
169
1250
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
32
164
1.96
3.19
1.6
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
118
847
1.41
3.14
1.7
1.6
iu/ml
21.6
0.2
0.67
20
164
(3003327) Ova and parasites identified in Stool by Light microscopy
120
866
1.40
3.10
1.8
1.8
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
12
39
3.08
3.09
1.8
1.6
u/l
12.2
60.6
0.64
12
33
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
27
132
2.05
3.06
1.3
1.1
miu/ml
1815.4
1521.1
0.72
27
132
(3026726) Creatinine [Moles/volume] in Specimen
6
8
7.51
3.05
4.8
4.1
umol/l
631.0
375.1
—
6
8
(3004716) Salmonella sp identified in Stool by Organism specific culture
192
1494
1.30
3.05
1.5
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
62
2.59
3.04
1.8
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
62
2.59
3.04
1.8
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
62
2.59
3.04
1.8
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
105
744
1.43
3.02
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
300
2470
1.24
2.99
3.6
2.3
umol/l
6.2
7.3
0.79
269
2102
(4027681)
32
168
1.91
2.99
1.3
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
81
2.35
2.98
1.7
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
81
2.35
2.98
1.7
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
81
2.35
2.98
1.7
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
81
2.35
2.98
1.7
1.4
—
—
—
0
0
(3047185) IgG [Mass/volume] in Urine
5
5
10.01
2.98
1.2
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
70
459
1.54
2.96
1.3
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
34
183
1.87
2.96
2.7
2.4
%
11.2
11.3
0.04
34
183
(3000012) Reticulocyte production index
20
88
2.28
2.93
1.2
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
63
405
1.57
2.91
1.9
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
44
258
1.72
2.90
1.7
1.4
g/l
0.3
0.4
0.82
34
185
(3028192) IgG subclass 2 [Mass/volume] in Serum
44
258
1.72
2.90
1.7
1.4
g/l
2.8
2.9
0.15
34
185
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
137
1024
1.35
2.88
2.1
1.9
u/l
39.3
39.0
0.06
128
917
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
13
5.39
2.87
1.1
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
44
259
1.71
2.87
1.7
1.4
g/l
5.9
6.5
0.66
34
187
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
102
2.17
2.86
1.8
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
116
847
1.38
2.83
1.5
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
387
3291
1.20
2.81
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
429
3684
1.19
2.80
1.5
1.4
titre
514.9
561.4
0.19
95
787
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
517
4511
1.18
2.79
1.3
1.3
u/ml
15.5
10.6
0.19
231
1841
(3009343) pH of Capillary blood
167
1292
1.31
2.79
5.5
3.3
ph
7.4
7.4
0.70
34
150
(3001019) Free T4 and TSH panel - Serum or Plasma
129
1710
0.74
2.78
1.9
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
39
224
1.75
2.77
1.0
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
169
1311
1.31
2.77
5.5
3.3
kpa
5.1
5.2
0.39
164
1203
(3027944) Amphetamines [Presence] in Urine
85
1201
0.70
2.72
1.9
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
17
72
2.37
2.72
1.5
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
79
1130
0.69
2.71
1.9
2.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
60
2.51
2.70
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
60
2.51
2.70
1.7
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
566
4990
1.16
2.68
1.6
1.6
pmol/l
12134325.4
36415786.6
1.00
478
4218
(3009871) Measles virus Ab [Titer] in Serum
20
92
2.18
2.67
2.0
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
19
86
2.22
2.63
1.2
1.0
—
—
—
0
0
(3036603) Volume of Urine
24
120
2.01
2.60
1.6
1.4
ml
2240.7
2134.6
—
9
22
(3028300) Cannabinoids [Presence] in Urine
88
1225
0.71
2.60
1.8
2.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
142
1086
1.32
2.60
1.1
1.1
u/ml
2.4
1.3
—
6
17
(3008295) Osmolality of Serum or Plasma
38
222
1.72
2.57
1.7
1.6
mosm/kgh2o
280.8
280.2
0.07
30
175
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
291
3463
0.82
2.56
1.8
1.7
%
1.4
1.4
0.43
259
3094
(3027008) Opiates [Presence] in Urine
88
1220
0.71
2.54
1.8
2.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2495
24223
1.15
2.53
15.6
12.0
%
39.6
40.2
2.34
1741
18351
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
179
1.80
2.51
1.2
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
18
82
2.20
2.47
1.2
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
36
210
1.72
2.46
1.1
1.1
mg/l
220.6
244.6
0.48
31
184
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
21
3.82
2.46
1.8
2.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
31
173
1.80
2.46
3.9
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
88
1212
0.72
2.46
1.8
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
32
544
0.58
2.43
2.5
2.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
352
3011
1.19
2.42
1.5
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
33
189
1.75
2.41
1.2
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
216
1765
1.24
2.36
3.1
2.9
ng/l
171.0
183.7
0.20
204
1610
(3039000) Anion gap in Blood
65
443
1.48
2.36
4.9
8.2
mmol/l
11.5
11.3
0.28
60
393
(3018572) Chloride [Moles/volume] in Blood
65
444
1.47
2.33
4.9
8.2
mmol/l
105.7
105.3
0.35
60
394
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
133
1027
1.31
2.31
6.7
4.0
mmol/l
23.7
24.2
1.20
120
915
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
35
207
1.70
2.30
1.2
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
28
156
1.80
2.25
1.2
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
70
980
0.71
2.19
1.3
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
104
782
1.34
2.18
1.1
1.1
u/ml
15.2
4.3
0.65
16
108
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
17
80
2.13
2.18
1.3
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
11
42
2.62
2.18
2.3
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1060
9857
1.11
2.16
3.2
2.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
48
313
1.54
2.16
1.3
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
14
4.29
2.15
1.0
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
62
429
1.45
2.12
2.2
2.2
umol/l
5.0
4.8
0.06
47
305
(3045142) Bone marrow Pathology biopsy report
26
145
1.80
2.10
1.2
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
43
2.56
2.09
1.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
23
124
1.86
2.06
1.4
1.6
u/l
14.6
6.2
—
10
63
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
59
407
1.46
2.05
1.4
1.2
ug/l
2.5
3.3
1.06
50
377
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
89
2.03
2.05
1.9
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
89
2.03
2.05
1.9
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
20
3.51
2.05
1.4
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
89
661
1.36
2.04
4.3
6.7
mmol/l
1.3
1.3
0.01
78
574
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
111
857
1.31
1.97
3.3
2.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
171
1.70
1.96
5.7
3.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
27
156
1.74
1.96
1.2
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
220
1843
1.21
1.94
2.4
2.3
au/ml
16.8
22.1
0.42
11
118
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
59
413
1.44
1.92
1.3
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
13
58
2.25
1.90
1.2
1.1
—
—
—
0
0
(4306422)
60
424
1.42
1.87
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
370
3254
1.16
1.84
1.9
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
466
0.62
1.83
1.4
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
580
5258
1.13
1.83
1.6
1.5
nmol/l
20.7
20.5
0.09
517
4532
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
66
900
0.73
1.81
1.2
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
53
2.27
1.80
1.2
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
12
53
2.27
1.80
1.1
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
66
899
0.73
1.80
1.2
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
18
94
1.92
1.80
2.4
2.1
ug/l
1.3
1.2
0.14
18
83
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
13
60
2.17
1.77
1.2
1.1
u/ml
106.0
50.1
1.09
13
60
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
66
896
0.73
1.77
1.2
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
26
155
1.68
1.72
2.0
1.7
—
1.8
—
0
13
(3050129) First trimester maternal screen panel - Serum or Plasma
139
1126
1.25
1.72
1.6
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
77
577
1.34
1.72
1.2
1.3
e6/l
20.4
27.9
0.15
70
457
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
13
3.85
1.71
1.4
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
13
3.85
1.71
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
58
415
1.41
1.71
2.2
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
77
578
1.34
1.70
1.3
1.4
e6/l
1818.0
1512.9
0.06
71
484
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
22
370
0.59
1.69
1.4
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
35
227
1.55
1.67
4.8
5.0
mmol/l
7.8
7.3
0.34
27
180
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
162
0.43
1.66
2.7
2.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
19
3.16
1.66
1.3
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
67
897
0.74
1.66
1.2
1.4
—
—
—
0
0
(4146454)
13
251
0.52
1.62
2.9
2.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
8
32
2.50
1.59
1.1
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
33
214
1.55
1.59
2.5
3.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
65
481
1.36
1.59
4.4
2.9
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
20
3.00
1.58
1.0
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
20
3.00
1.58
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
17
92
1.85
1.56
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
435
3916
1.13
1.55
3.0
2.6
ug/l
0.7
0.7
0.35
281
2472
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
33
2.43
1.53
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
33
2.43
1.53
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
33
2.43
1.53
1.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
15
3.34
1.52
1.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
52
374
1.40
1.52
1.6
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
26
407
0.64
1.52
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
44
307
1.44
1.52
1.2
1.2
nmol/l
—
—
—
0
0
(3019977) pH of Arterial blood
19
108
1.76
1.50
1.7
2.6
ph
7.4
7.4
—
9
32
(3037121) Protein [Mass/volume] in Urine
91
714
1.28
1.50
4.8
3.0
g/l
0.3
0.3
0.35
48
245
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
197
1680
1.18
1.49
1.3
1.3
au/ml
72.4
45.3
—
5
70
(4034850)
67
876
0.76
1.44
12.2
8.9
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
16
3.13
1.44
1.0
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
33
220
1.51
1.43
1.2
1.3
e6/l
169291.2
121283.0
0.11
21
151
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
227
0.53
1.43
1.8
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
39
2.31
1.43
1.9
1.5
ng/l
138.4
127.9
—
9
39
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
29
188
1.55
1.42
1.1
1.3
u/ml
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
138
1147
1.21
1.39
2.3
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
66
858
0.76
1.37
2.2
2.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
54
399
1.36
1.37
1.6
1.7
g/l
0.5
0.8
1.28
44
311
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
26
166
1.57
1.37
1.0
1.1
iu/ml
8.9
11.7
—
10
42
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
17
2.94
1.36
1.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
35
240
1.46
1.34
1.3
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
14
75
1.87
1.34
1.5
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
35
241
1.46
1.32
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
128
1064
1.21
1.30
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
714
6663
1.09
1.30
1.7
1.6
mmol/l
1.3
1.4
0.61
605
5679
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
41
292
1.41
1.30
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
35
242
1.45
1.30
1.3
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
21
129
1.63
1.29
1.7
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
29
194
1.50
1.26
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
66
510
1.30
1.26
1.7
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
117
0.43
1.24
1.0
1.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
99
807
1.23
1.23
1.8
1.6
titre
576.0
393.0
—
5
40
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
45
2.00
1.23
1.4
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
35
245
1.43
1.23
1.3
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
22
139
1.59
1.23
1.6
1.6
e6/l
12107.8
74850.6
0.78
17
82
(3025577) Chromium [Mass/volume] in Blood
7
145
0.48
1.19
2.6
2.0
ug/l
3.0
2.3
—
7
125
(3024522) Salmonella sp identified in Specimen by Organism specific culture
35
247
1.42
1.19
1.3
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
26
2.31
1.18
1.7
2.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
18
109
1.66
1.18
1.9
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
25
166
1.51
1.14
1.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
40
541
0.74
1.14
1.3
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
479
4418
1.10
1.13
3.9
3.5
ng/l
617.7
548.8
0.11
340
3177
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
261
2919
0.88
1.13
4.8
4.3
%
33.9
32.2
1.74
186
2026
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
25
167
1.50
1.12
1.4
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
19
119
1.60
1.11
2.2
2.4
u/ml
487.8
811.8
1.64
19
119
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
35
251
1.40
1.10
1.3
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
32
227
1.41
1.07
1.4
1.4
nmol/l
1.6
1.5
0.20
27
204
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
20
129
1.55
1.05
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
99
1184
0.83
1.05
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
50
384
1.31
1.04
1.1
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
46
1.96
1.03
1.2
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
235
2101
1.13
1.00
3.7
2.3
u/l
31.6
60.2
0.67
208
1776
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
22
147
1.50
1.00
1.4
1.4
—
592.5
—
0
12
(3013637) Mi-2 Ab [Presence] in Serum
12
68
1.77
1.00
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
68
1.77
1.00
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
68
1.77
1.00
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
68
1.77
1.00
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
45
584
0.77
0.99
2.8
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
349
3199
1.10
0.96
1.7
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
224
2005
1.13
0.95
1.3
1.2
iu/ml
96.7
150.9
2.04
96
774
(3016650) Hepatitis A virus Ab [Presence] in Serum
52
408
1.28
0.94
1.2
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
6
27
2.22
0.93
1.0
1.3
—
276.0
—
0
6
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
16
101
1.59
0.93
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
142
0.56
0.93
1.3
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
46
356
1.30
0.93
1.2
1.2
u/l
25.9
20.4
0.18
40
306
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
52
410
1.27
0.91
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
12
195
0.61
0.90
1.4
1.3
—
1.5
—
0
13
(3024263) Appearance of Synovial fluid
20
135
1.48
0.89
2.1
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
54
430
1.26
0.88
1.3
1.2
u/ml
1.5
4.6
2.20
15
147
(3000285) Sodium [Moles/volume] in Blood
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
30
2.00
0.87
1.2
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
64
1.72
0.86
1.2
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
8
44
1.82
0.85
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
194
1736
1.13
0.85
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
44
344
1.28
0.84
3.3
3.2
nmol/l
0.9
0.8
0.20
35
264
(40765096) Chromosome analysis panel by Banding
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
8
45
1.78
0.84
1.0
2.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
30
222
1.35
0.83
1.7
1.4
%
35.1
30.6
0.25
18
137
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
22
154
1.43
0.83
1.3
1.4
mmol/l
5.5
5.8
0.63
22
149
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
65
1.69
0.82
1.2
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
32
1.88
0.81
3.2
7.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
110
951
1.16
0.80
5.9
3.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
73
609
1.20
0.80
1.1
1.1
u/ml
1.2
1.4
0.13
25
239
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
375
3485
1.09
0.79
1.9
2.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
194
1745
1.12
0.79
1.8
2.6
e9/l
4.6
4.1
1.46
170
1384
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
131
1149
1.15
0.79
1.5
1.7
mg/l
2.4
4.2
1.62
91
789
(40768806) Pleura Pathology biopsy report
17
114
1.49
0.79
1.4
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
28
208
1.35
0.77
1.2
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
114
995
1.15
0.75
8.9
10.0
mmol/l
24.0
24.3
0.55
102
922
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
11
67
1.64
0.75
1.2
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
67
1.64
0.75
1.9
2.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
75
633
1.19
0.74
3.9
3.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
78
661
1.18
0.74
1.6
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
9
55
1.64
0.73
1.4
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
23
167
1.38
0.73
3.4
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
24
176
1.37
0.72
1.1
1.2
ratio
1.1
1.0
—
8
67
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
18
125
1.44
0.72
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(4094501)
81
691
1.18
0.72
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
11
68
1.62
0.71
1.2
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
12
76
1.58
0.71
5.2
3.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
47
577
0.81
0.71
1.3
1.2
u/ml
2.6
6.5
—
7
45
(3007566) Smooth muscle Ab [Titer] in Serum
77
655
1.18
0.71
1.4
1.3
titre
69.1
97.3
0.86
11
63
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
182
0.66
0.70
1.2
1.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
20
143
1.40
0.70
1.4
1.4
—
65.0
—
0
12
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
142
0.63
0.69
1.6
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
241
2214
1.10
0.68
1.1
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
27
1.85
0.68
1.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
34
266
1.28
0.68
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
50
410
1.22
0.68
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
50
410
1.22
0.68
1.3
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
25
187
1.34
0.68
1.0
1.0
—
—
—
0
0
(4268621)
37
293
1.27
0.68
2.2
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
772
1.16
0.66
1.9
1.3
g/l
4.2
3.9
0.24
56
562
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
772
1.16
0.66
2.0
1.3
g/l
7.5
7.4
0.23
56
588
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
772
1.16
0.66
1.9
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
76
884
0.86
0.66
1.7
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1787
17511
1.05
0.65
3.4
2.9
u/l
43.3
41.9
0.33
1705
16454
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
44
1.59
0.65
1.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
11
70
1.57
0.65
1.2
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(44813793)
25
190
1.32
0.62
1.2
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
17
234
0.72
0.62
1.5
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
68
581
1.17
0.62
1.6
1.6
e6/l
27227.8
11061.7
0.35
45
426
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
71
1.55
0.62
1.2
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
71
1.55
0.62
1.1
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
187
0.69
0.61
1.5
1.5
—
67.6
—
0
22
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
47
389
1.21
0.60
1.3
1.4
mmol/l
7.0
7.4
0.49
38
282
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
250
2694
0.92
0.60
1.8
1.7
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
3.0
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
4.9
—
0
5
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
63
736
0.85
0.59
1.3
1.3
u/ml
3.2
5.7
—
8
121
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
161
1464
1.11
0.59
1.1
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
61
521
1.17
0.57
8.8
2.2
nmol/l
0.9
0.8
0.46
54
434
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
38
1.58
0.54
1.2
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
51
600
0.85
0.54
1.3
1.2
u/ml
57.1
44.4
—
7
60
(3051651) Icteric interference index of Serum or Plasma
15
108
1.39
0.53
9.4
4.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
35
286
1.23
0.52
2.0
2.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
40
1.50
0.51
2.8
2.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
63
725
0.87
0.51
1.4
1.2
u/ml
1.4
6.8
—
6
74
(3043410) Blood group antigens tested for on Red Blood Cells
9
64
1.41
0.51
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
41
1.46
0.50
3.5
2.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
53
454
1.17
0.50
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
410
3903
1.06
0.49
2.0
2.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
12
85
1.41
0.46
1.0
1.1
u/ml
0.1
2.9
—
5
49
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
49
420
1.17
0.46
1.4
1.3
u/ml
6.0
5.5
0.08
24
180
(40768441) Liver Pathology biopsy report
18
138
1.31
0.45
2.0
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
121
0.66
0.45
1.3
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
52
450
1.16
0.44
1.0
1.1
u/ml
3.5
3.4
0.00
23
169
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
112
1.34
0.44
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77
862
0.89
0.44
1.6
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
73
649
1.13
0.43
1.4
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
116
1059
1.10
0.43
1.7
2.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
22
175
1.26
0.43
1.2
1.1
nmol/l
—
9.7
—
0
37
(4281824)
17
131
1.30
0.42
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
223
2097
1.07
0.41
6.5
3.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
13
96
1.36
0.41
1.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
27
326
0.83
0.41
1.3
1.3
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
0.4
—
0
11
(3041672) Baker's yeast Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.3
—
0
10
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
159
1.26
0.40
1.2
1.1
u/l
1.0
1.1
—
8
76
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
20
159
1.26
0.40
1.1
1.6
u/l
5.0
7.0
1.43
15
142
(3010937) Rubella virus Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
0.2
—
0
8
(3007700) Barley IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
1.1
—
0
10
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
88
1.37
0.40
1.5
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
88
1.37
0.40
1.5
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
101
0.69
0.39
1.3
1.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
10
71
1.41
0.39
2.0
1.8
—
164.1
—
0
9
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.3
—
21.7
—
0
19
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
30
251
1.20
0.39
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
115
1.31
0.38
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
17
133
1.28
0.38
1.4
1.4
nmol/l
146.8
139.3
0.45
17
133
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
67
1.34
0.38
1.4
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
72
1.39
0.37
1.4
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
71
1.27
0.36
3.4
4.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
21
171
1.23
0.35
1.6
2.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
13
99
1.31
0.35
1.2
1.1
%
116.0
109.2
0.66
13
85
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
43
1.40
0.35
1.3
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
35
303
1.16
0.33
1.7
1.5
%
58.2
60.7
0.13
20
193
(3039443) Prostate specific Ag panel - Serum or Plasma
41
466
0.88
0.32
2.1
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
46
407
1.13
0.32
1.2
1.0
u/ml
3.8
2.4
0.28
24
203
(3012441) Differential panel - Pleural fluid
17
137
1.24
0.32
1.6
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
13
165
0.79
0.32
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
175
1852
0.94
0.31
1.5
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
124
1158
1.07
0.31
1.9
1.7
mu/l
293.7
296.3
0.04
118
1044
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
52
1.35
0.31
1.0
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
60
662
0.90
0.30
1.1
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
79
725
1.09
0.30
2.0
1.4
g/l
3.1
3.1
0.23
56
575
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
111
1.26
0.30
1.1
3.3
umol/l
80.9
158.1
—
7
70
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
717
1.09
0.29
2.0
1.4
g/l
9.2
10.5
2.47
65
616
(3023430) Cat dander IgE Ab [Units/volume] in Serum
46
412
1.12
0.28
1.0
1.1
u/ml
2.7
4.2
0.74
19
163
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
182
1730
1.06
0.28
1.5
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
26
224
1.16
0.27
2.1
1.4
g/l
0.9
1.0
0.73
26
224
(3023511) Choriogonadotropin [Units/volume] in Urine
66
719
0.92
0.27
1.6
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
56
509
1.10
0.27
1.0
1.1
u/ml
2.3
2.3
0.00
16
121
(3017704) Immunofixation for Urine
13
104
1.25
0.26
1.2
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
67
1.19
0.26
1.6
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
67
1.19
0.26
1.6
2.9
—
—
—
0
0
(4133840)
5
71
0.70
0.26
1.2
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
138
0.80
0.25
2.5
1.9
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
24
207
1.16
0.25
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
24
207
1.16
0.25
1.3
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
75
1.20
0.25
3.8
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
37
413
0.89
0.24
2.2
1.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
16
191
0.84
0.24
19.0
17.5
nmol/l
1623.5
1485.0
0.41
16
186
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
78
1.28
0.24
1.2
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
24
208
1.16
0.24
1.3
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
169
0.83
0.24
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
48
437
1.10
0.23
1.7
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
38
1.32
0.23
1.6
6.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
88
824
1.07
0.23
6.0
3.5
mmol/l
24.1
24.7
1.36
83
757
(4211845)
11
136
0.81
0.23
1.6
3.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
190
1.16
0.23
1.3
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
39
1.28
0.23
1.4
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
24
209
1.15
0.22
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
24
209
1.15
0.22
1.3
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
40
1.25
0.22
1.4
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
72
671
1.07
0.21
1.9
2.0
iu/l
2.9
4.4
3.11
27
262
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
24
210
1.14
0.21
1.3
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
107
1.22
0.21
1.6
2.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.2
—
0.0
—
0
11
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
16
188
0.85
0.21
11.4
12.6
nmol/l
1016.3
833.4
0.76
16
182
(3036071) Salmonella sp Ab [Titer] in Serum
12
98
1.23
0.21
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
104
0.77
0.21
1.0
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
63
585
1.08
0.21
1.3
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
43
1.16
0.21
1.6
1.8
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
28
249
1.13
0.20
1.4
1.4
mmol/l
9.3
11.8
—
6
55
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
1.4
—
0
14
(4015189)
6
52
1.15
0.19
3.2
2.6
—
—
—
0
0
(3000492) Spirometry study
245
2528
0.97
0.19
1.5
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
143
0.84
0.18
1.6
1.9
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
24
213
1.13
0.18
1.7
1.2
u/ml
1.3
0.5
0.55
14
85
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
157
1.15
0.17
1.4
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
15
129
1.16
0.17
1.2
1.1
iu/ml
294.4
185.7
0.26
15
129
(3020650) Glucose [Presence] in Urine
5
69
0.72
0.17
1.0
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
246
0.89
0.16
1.3
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
206
1.12
0.16
1.6
1.4
—
—
—
0
0
(4024509)
24
216
1.11
0.15
1.6
1.6
—
—
—
0
0
(4198724)
10
119
0.84
0.15
2.9
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
119
1146
1.04
0.14
1.6
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
43
458
0.94
0.13
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
55
521
1.06
0.12
1.1
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
152
1.12
0.12
1.2
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
43
456
0.94
0.11
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
45
425
1.06
0.11
1.2
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
23
250
0.92
0.11
1.4
1.6
mmol/l
6.9
7.7
1.37
17
151
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
86
1.16
0.11
1.8
1.5
ug/l
8.5
8.4
—
10
86
(3044927) Protein electrophoresis panel - Urine
23
212
1.09
0.10
1.2
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
67
643
1.04
0.10
2.5
1.4
g/l
1.1
0.4
0.69
57
569
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
38
401
0.95
0.09
1.3
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
60
0.83
0.08
10.6
7.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
60
579
1.04
0.07
2.1
1.3
g/l
0.0
0.0
0.25
55
539
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
59
611
0.96
0.07
2.1
1.3
g/l
36.4
38.1
1.28
52
526
(3014271) Vancomycin [Susceptibility]
9
86
1.05
0.07
2.4
2.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
88
1.02
0.07
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
15
162
0.93
0.06
1.1
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
11
121
0.91
0.06
1.6
3.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
160
1624
0.98
0.05
2.5
2.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
49
504
0.97
0.04
3.2
3.3
mg/l
17.7
24.5
1.48
32
321
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
103
1013
1.02
0.04
1.7
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
84
856
0.98
0.04
2.0
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
15
160
0.94
0.04
1.1
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
121
1.07
0.03
2.2
1.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
56
548
1.02
0.03
1.1
1.1
u/ml
3.1
5.6
1.45
30
288
(3016018) Differential panel - Cerebral spinal fluid
27
260
1.04
0.03
1.1
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
44
429
1.03
0.03
2.4
3.0
umol/l
32.6
36.6
0.42
39
377
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
19
181
1.05
0.03
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
102
1.08
0.03
1.2
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
43
420
1.02
0.02
1.2
1.1
iu/ml
55.0
23404.2
—
10
100
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
37
379
0.98
0.02
1.0
1.1
u/ml
1.1
0.4
—
8
87
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
11
103
1.07
0.02
1.0
1.1
—
4.5
—
0
17
(3051611) Lipemic interference index of Serum or Plasma
20
193
1.04
0.01
7.8
3.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
203
1.03
0.01
4.5
4.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
25
243
1.03
0.01
1.9
2.3
mg/l
23.1
21.3
—
8
67
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
77
776
0.99
0.00
1.8
1.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
105
1.05
0.00
1.3
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
169
1.01
0.00
1.4
2.2
u/field
1.9
1.9
—
7
77
(3008401) Mugwort IgE Ab [Units/volume] in Serum
52
525
0.99
0.00
1.1
1.1
u/ml
0.6
1.1
0.48
19
219
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
116
1.03
0.00
1.4
2.0
ug/l
22.9
287.7
0.68
12
105
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
18
182
0.99
0.00
1.3
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
54
538
1.00
0.00
2.2
1.3
g/l
0.0
0.0
0.00
49
503
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
54
543
0.99
0.00
2.2
1.3
g/l
0.0
0.0
0.00
49
504
(3041806) Other cells [#/volume] in Blood by Manual count
12
117
1.03
0.00
1.7
1.6
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1712.2
—
0
5
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.8
—
0.2
—
0
5
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
49
1.02
0.00
2.4
1.4
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
40.1
—
0
5
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
4.6
—
0
5
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
7.7
—
0
5
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
2.9
—
0
5
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
99.1
—
0
5
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
5
51
0.98
0.00
1.0
1.1
—
7.7
—
0
8
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
67
0.90
0.00
9.5
7.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
97
0.93
0.00
4.3
9.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
6
61
0.98
0.00
2.2
1.6
ug/l
0.5
0.4
—
6
34
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
51
0.98
0.00
1.4
2.3
mmol/l
1.2
1.2
—
5
51
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
6
0.00
0.00
0.0
1.2
—
66.1
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.5
—
0
6
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_NOS_EXALLC – Melanocytic naevi, other sites/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).